112 related articles for article (PubMed ID: 17167714)
1. Effect of proteasome inhibitors on expression of HLA-G isoforms.
Poláková K; Bandzuchová E; Bystrická M; Pancuchárová H; Russ G
Neoplasma; 2006; 53(6):471-7. PubMed ID: 17167714
[TBL] [Abstract][Full Text] [Related]
2. Identification of HLA-G7 as a new splice variant of the HLA-G mRNA and expression of soluble HLA-G5, -G6, and -G7 transcripts in human transfected cells.
Paul P; Cabestre FA; Ibrahim EC; Lefebvre S; Khalil-Daher I; Vazeux G; Quiles RM; Bermond F; Dausset J; Carosella ED
Hum Immunol; 2000 Nov; 61(11):1138-49. PubMed ID: 11137219
[TBL] [Abstract][Full Text] [Related]
3. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?
Rouas-Freiss N; Marchal RE; Kirszenbaum M; Dausset J; Carosella ED
Proc Natl Acad Sci U S A; 1997 May; 94(10):5249-54. PubMed ID: 9144223
[TBL] [Abstract][Full Text] [Related]
4. The full length HLA-G1 and no other alternative form of HLA-G is expressed at the cell surface of transfected cells.
Mallet V; Pröll J; Solier C; Aguerre-Girr M; DeRossi M; Loke YW; Lenfant F; Le Bouteiller P
Hum Immunol; 2000 Mar; 61(3):212-24. PubMed ID: 10689111
[TBL] [Abstract][Full Text] [Related]
5. Full-length HLA-G1 and truncated HLA-G3 differentially increase HLA-E surface localization.
Teklemariam T; Zhao L; Hantash BM
Hum Immunol; 2012 Sep; 73(9):898-905. PubMed ID: 22732094
[TBL] [Abstract][Full Text] [Related]
6. HLA-G truncated isoforms can substitute for HLA-G1 in fetal survival.
Menier C; Riteau B; Dausset J; Carosella ED; Rouas-Freiss N
Hum Immunol; 2000 Nov; 61(11):1118-25. PubMed ID: 11137216
[TBL] [Abstract][Full Text] [Related]
7. Endoplasmic reticulum aminopeptidase-1 mediates leukemia inhibitory factor-induced cell surface human leukocyte antigen-G expression in JEG-3 choriocarcinoma cells.
Shido F; Ito T; Nomura S; Yamamoto E; Sumigama S; Ino K; Itakura A; Hattori A; Tsujimoto M; Mizutani S; Kikkawa F
Endocrinology; 2006 Apr; 147(4):1780-8. PubMed ID: 16439450
[TBL] [Abstract][Full Text] [Related]
8. Differences in the expression of human class I MHC alleles and their associated peptides in the presence of proteasome inhibitors.
Luckey CJ; Marto JA; Partridge M; Hall E; White FM; Lippolis JD; Shabanowitz J; Hunt DF; Engelhard VH
J Immunol; 2001 Aug; 167(3):1212-21. PubMed ID: 11466336
[TBL] [Abstract][Full Text] [Related]
9. Placental cell expression of HLA-G2 isoforms is limited to the invasive trophoblast phenotype.
Morales PJ; Pace JL; Platt JS; Phillips TA; Morgan K; Fazleabas AT; Hunt JS
J Immunol; 2003 Dec; 171(11):6215-24. PubMed ID: 14634138
[TBL] [Abstract][Full Text] [Related]
10. Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine.
Yan WH; Lin AF; Chang CC; Ferrone S
Cell Res; 2005 Jul; 15(7):523-31. PubMed ID: 16045815
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of HLA-G production in JEG-3 choriocarcinoma cells by RNA interference.
Wengenmayer T; Poehlmann TG; Markert UR
Am J Reprod Immunol; 2004 Mar; 51(3):189-91. PubMed ID: 15209386
[TBL] [Abstract][Full Text] [Related]
12. Modulation of HLA-G expression.
Polakova K; Bandzuchova E; Tirpakova J; Kuba D; Russ G
Neoplasma; 2007; 54(6):455-62. PubMed ID: 17949227
[TBL] [Abstract][Full Text] [Related]
13. [Effects on human leukocyte antigen-G on proliferation and invasion of JEG-3 cell line].
Liu HY; Gu WR; Li XT
Zhonghua Fu Chan Ke Za Zhi; 2008 Jun; 43(6):445-50. PubMed ID: 19035141
[TBL] [Abstract][Full Text] [Related]
14. The short forms of HLA-G are unlikely to play a role in pregnancy because they are not expressed at the cell surface.
Bainbridge DR; Ellis SA; Sargent IL
J Reprod Immunol; 2000 May; 47(1):1-16. PubMed ID: 10779586
[TBL] [Abstract][Full Text] [Related]
15. Molecular studies of trophoblast HLA-G: polymorphism, isoforms, imprinting and expression in preimplantation embryo.
Hiby SE; King A; Sharkey A; Loke YW
Tissue Antigens; 1999 Jan; 53(1):1-13. PubMed ID: 10082426
[TBL] [Abstract][Full Text] [Related]
16. Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzyme peroxiredoxin 5.
Sensi M; Pietra G; Molla A; Nicolini G; Vegetti C; Bersani I; Millo E; Weiss E; Moretta L; Mingari MC; Anichini A
Int Immunol; 2009 Mar; 21(3):257-68. PubMed ID: 19181932
[TBL] [Abstract][Full Text] [Related]
17. Distribution of HLA-G alternative mRNAs including soluble forms in normal lymphocytes and in lymphoid cell-derived leukemia.
Amiot L; Onno M; Drénou B; le Marchand B; Lamy T; Semana G; Fauchet R
Eur J Immunogenet; 1996 Aug; 23(4):311-20. PubMed ID: 8858287
[TBL] [Abstract][Full Text] [Related]
18. Does 'soluble' HLA-G really exist? Another twist to the tale.
Sargent IL
Mol Hum Reprod; 2005 Oct; 11(10):695-8. PubMed ID: 16330473
[TBL] [Abstract][Full Text] [Related]
19. The possible use of HLA-G1 and G3 in the inhibition of NK cell-mediated swine endothelial cell lysis.
Matsunami K; Miyagawa S; Nakai R; Murase A; Shirakura R
Clin Exp Immunol; 2001 Oct; 126(1):165-72. PubMed ID: 11678914
[TBL] [Abstract][Full Text] [Related]
20. Soluble HLA-G generated by proteolytic shedding inhibits NK-mediated cell lysis.
Park GM; Lee S; Park B; Kim E; Shin J; Cho K; Ahn K
Biochem Biophys Res Commun; 2004 Jan; 313(3):606-11. PubMed ID: 14697234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
